{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:50:11Z","timestamp":1773298211914,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.juro.2015.05.099","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T02:57:30Z","timestamp":1434164250000},"page":"1612-1616","source":"Crossref","is-referenced-by-count":47,"title":["Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer"],"prefix":"10.1097","volume":"194","author":[{"given":"Jacques","family":"Baillargeon","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahakn B.","family":"Shahinian","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.05.099_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jamainternmed.2013.6895","article-title":"Trends in androgen prescribing in the United States, 2001-2011","volume":"173","author":"Baillargeon","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.juro.2015.05.099_bib2","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1210\/jc.2009-2354","article-title":"Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline","volume":"95","author":"Bhasin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2015.05.099_bib3","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a\u00a0meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.juro.2015.05.099_bib4","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1210\/jc.2009-2575","article-title":"Adverse effects of testosterone therapy in\u00a0adult men: a systematic review and meta-analysis","volume":"95","author":"Fernandez-Balsells","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2015.05.099_bib5","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/j.1743-6109.2012.02808.x","article-title":"Is testosterone treatment good for the prostate? Study of safety during long-term treatment","volume":"9","author":"Fenely","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.05.099_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-5347(17)54531-0","article-title":"The response of metastatic adenocarcinoma of the prostate to exogenous testosterone","volume":"126","author":"Fowler","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.05.099_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/2042098614548680","article-title":"Adverse effects of testosterone replacement therapy: an update on the evidence and controversy","volume":"5","author":"Grech","year":"2014","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.juro.2015.05.099_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrurol.2014.338","article-title":"Testosterone therapy and prostate cancer-safety concerns are well founded","volume":"12","author":"Klotz","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2015.05.099_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ucl.2007.08.002","article-title":"Testosterone replacement therapy and prostate cancer","volume":"34","author":"Morgentaler","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2015.05.099_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2006.06.034","article-title":"Testosterone and prostate cancer: an historical perspective on a modern myth","volume":"50","author":"Morgentaler","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.05.099_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ucl.2011.02.002","article-title":"Testosterone and prostate cancer: what are the risks for middle-aged men?","volume":"38","author":"Morgentaler","year":"2011","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2015.05.099_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.05.099_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1464-410X.2008.08240.x","article-title":"Prostate specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy","volume":"103","author":"Coward","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.05.099_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrendo.2013.73","article-title":"Risks and benefits of testosterone therapy in older men","volume":"9","author":"Spitzer","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.juro.2015.05.099_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.ijir.3901418","article-title":"Testosterone replacement therapy and the risk of prostate cancer: is there a link?","volume":"18","author":"Barqawi","year":"2006","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.juro.2015.05.099_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.pcan.4500839","article-title":"Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer","volume":"9","author":"Gould","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2015.05.099_bib17","first-page":"293","article-title":"Studies on prostate cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2015.05.099_bib18","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2003-032006","article-title":"Long-term testosterone gel treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.juro.2015.05.099_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ijir.2008.31","article-title":"Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review","volume":"21","author":"Shabsigh","year":"2009","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.juro.2015.05.099_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.urology.2013.03.049","article-title":"Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes","volume":"82","author":"Kaplan","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.05.099_bib21","doi-asserted-by":"crossref","first-page":"IV-3","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.juro.2015.05.099_bib22","doi-asserted-by":"crossref","first-page":"IV-26","DOI":"10.1097\/00005650-200208001-00004","article-title":"Assessing comorbidity using claims data: an overview","volume":"40","author":"Klabunde","year":"2002","journal-title":"Med Care"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715041488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715041488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.05.099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:02:40Z","timestamp":1651204960000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.05.099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1016\/j.juro.2015.05.099"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.05.099","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}